Original research
par
Martin, Rosemarie A. et al
Date de publication
2022
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
Few jails and prisons offer MOUD and most limit access. Extended-release buprenorphine (XR-BUP), a novel monthly injectable MOUD formulation, could be uniquely poised to address treatment access in correctional settings.
Constatations/points à retenir
XR-BUP is feasible and acceptable in correctional settings. XR-BUP addresses administrative concerns of diversion that obstruct lifesaving MOUD and offers another safe and effective treatment option.
La conception ou méthodologie de recherche
Retrospective cohort study (n=54)
Mots clés
Legal system/law enforcement
Diversion
Substitution/OAT
Outcomes
